Prospective study of oral adverse events by anti-cancer therapy with immune checkpoint inhibitors
Not Applicable
- Conditions
- Oral mucositis
- Registration Number
- JPRN-UMIN000041688
- Lead Sponsor
- Tohoku University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who are unable to get informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Grade of oral oral mucositis
- Secondary Outcome Measures
Name Time Method Examination of dental condition